PENK Methylation Test for Detecting Bladder Cancer

Clinical trial NCT05220189 · UNKNOWN

Trial details

NCT number: NCT05220189
Sponsor: Asan Medical Center
Status: UNKNOWN
Study type: OBSERVATIONAL

Bladder Cancer Hematuria; Benign

Start date: 2022-02-03
Primary completion: 2023-12-31
Enrollment: 1549

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.